These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31439237)

  • 1. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy.
    Boudinaud C; Abergel A; Joubert-Zakeyh J; Fontarensky M; Pereira B; Chauveau B; Garcier JM; Chabrot P; Boyer L; Magnin B
    Eur J Radiol; 2019 Sep; 118():169-174. PubMed ID: 31439237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
    Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.
    França M; Alberich-Bayarri Á; Martí-Bonmatí L; Oliveira P; Costa FE; Porto G; Vizcaíno JR; Gonzalez JS; Ribeiro E; Oliveira J; Pessegueiro Miranda H
    Abdom Radiol (NY); 2017 May; 42(5):1434-1443. PubMed ID: 28110367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
    World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study.
    Idilman IS; Celik A; Savas B; Idilman R; Karcaaltincaba M
    Clin Radiol; 2021 Sep; 76(9):709.e13-709.e18. PubMed ID: 34266657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload.
    Uhrig M; Mueller J; Longerich T; Straub BK; Buschle LR; Schlemmer HP; Mueller S; Ziener CH
    Magn Reson Imaging; 2019 Nov; 63():114-122. PubMed ID: 31425813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying steatosis in the liver and pancreas with MRI in patient with chronic liver disease.
    Vieira J; Amorim J; Martí-Bonmatí L; Alberich-Bayarri Á; França M
    Radiologia (Engl Ed); 2020; 62(3):222-228. PubMed ID: 31932016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI versus histological methods for time course monitoring of steatosis amount in a murine model of NAFLD.
    Leiber LM; Boursier J; Michalak S; Roullier V; Fizanne L; Chaigneau J; Roux J; Moal V; Flamment M; Bazeries P; Ducluzeau PH; Aube C
    Diagn Interv Imaging; 2015 Sep; 96(9):915-22. PubMed ID: 25934180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.